Abstract. The present experiments were designed to clarify the relationship between cAMP elevation, proliferation and differentiation in Schwann cells. They were carried out on short-term cultures of cells obtained from neonatal rat sciatic nerves.
and absence of myelin-related differentiation. The cAMP mediated induction of an early Schwann cell antigen, 04, followed a different pattern since it was induced equally in dividing and nondividing cells.
These observations are consistent with the proposal that during development of the rat sciatic nerve: (a) cAMP elevation, possibly induced by axon-associated factors, is a primary signal responsible for the induction of 04 expression in proliferating Schwann cells during the premyelination period; (b) subsequent withdrawal of cells associated with the larger axons from the cell cycle acts as a permissive secondary signal for induction of myelination, since in quiescent cells the ongoing cAMP elevation will trigger myelination.
T hE adenyl cyclase-cAMP second messenger pathway has been implicated in the regulation of growth and development in several cell types, including Schwann cells, the major glial element in peripheral nerves. Thus, cAMP elevation stimulates DNA synthesis in Schwann cells cultured in the presence of serum or growth factors (9, 10, 14, 40, 42, 43, 51) . In cultured Schwann cells it also triggers the surface expression of two lipids, galactocerebroside and 04 (sulfatide), both of which are found on myelin-forming and non-myelin-forming Schwann cells in adult nerves (20, 32, 50, 51) . During development of the rat sciatic nerve, galactocerebroside appears at embryo day(E) 18-19 in cells destined to form myelin, and during the second to fifth postnatal week in non-myelin-forming cells. 04 on the other hand is an early Schwann cell differentiation marker appearing at El6. The effect of cAMP on induction of the major myelin glycoprotein Po is more controversial. Although it has been reported that elevation of cAMP does not induce Po in short-term cultured Schwann cells (49, 51) , other studies show that cAMP induces expression of Po and also induces Po mRNA and myelin basic protein mRNA in long-term Schwann cell cultures that have previously been exposed to mitogenic stimulation (24) .
These in vitro studies suggest that cAMP might be an intracellular signal during several different stages of Schwann cell development. In synergy with other factors, it might drive Schwann cel ! proliferation in developing nerves; it could act as a signal triggering early Schwann cell differentiation, i.e., 04 appearance; or it could be a signal for the emergence of the myelin phenotype or for the final maturation of nonmyelin-forming cells.
The proposal that cAMP elevation is involved in regulation of these disparate events during the in vivo development of the rat sciatic nerve raises at least three questions. First, does cAMP elevation unambiguously mimic myelin-related differentiation in rat Schwann cells? Second, if so, what is the timing mechanism that in vivo would allow cAMP elevation to induce 04 at El6 (32) but myelin-related differentiation, as exemplified by Po expression, 5-6 d later (around birth) (29.55) . Third, is induction of the myelin phenotype by cAMP in cultured cells incompatible with stimulation of DNA synthesis, as predicted by the observation that in vivo myelinrelated differentiation does not occur in dividing ceils (56) .
To answer these questions we have investigated the relationship between induction of the myelin phenotype, induction of 04 expression and stimulation of DNA synthesis. We show for the first time that in short-term Schwann cell cultures elevation of intracellular cAMP not only induces expression of Po but, in the same cells, triggers downregulation of several proteins normally downregulated during myelination in vivo, including GFAP, N-CAM, and ASE3, and also nerve growth factor (NGF) receptors (NGFR) ~ detected by the 217c antibody (8, 15, 18, 21, 23, 26, 27, 3t, 36) . Significantly, we find that in short-term Schwann cell cultures, these changes only take place if the proliferative response to cAMP is prevented. In contrast, 04 expression is readily induced by cAMP in dividing cells.
These observations, and earlier work on the regulation of galactocerebroside expression are consistent with the proposal that cAMP acts as a second messenger of an early and general Schwann cell differentiation signal. They also suggest that factors regulating Schwann cell proliferation control the transition from the premyelin to the myelin phenotype.
Materials and Methods

Schwann Cell Culture
Sciatic nerves were dissected from early postnatal rats (5-7 d) and desheathed. 5-d rats were used in most experiments. The tissue was dissociated essentially by the method of Brockes et al. (4) , and maintained in DMEM with added glutamine, insulin, and 10% calf serum. Cytosine arabinoside, 10 -5 M, was added after 24 h for 48 h to give cultures that were 95 % pure (4) . On the fourth day cells were plated on to coverslips coated with polylysine, polylysine plus laminin, or extracellular matrix as required, at a density of between 2.5-20,000 cells/coverslip. Cells were left for 24 h before further treatment. In most experiments, Schwann cells were cultured on laminin but in some experiments, polylysine or coverslips coated with extracellular matrix from bovine corneal endothelial cells were used. Cells were cultured in defined medium consisting of a 1:1 mixture of DMEM and Ham's F12 medium supplemented with selenium (100/zg.ml-t), triiodothyronine (0.1 /zg.ml-l), transferrin (100 #g.ml-l), putrescine (16 /~g.ml-t), thyroxine (0.4/~g.ml-t), progesterone (60 ~g-ml-t), 30% BSA (Path-o-cyte, ICN Immunologicals, Lisle, IL) (0.3 mg.ml-~), dexamethasone (38 ng.ml-l), insulin (5 #g.mi-l) with or without the addition of NGF (10 U.mi-l), glucose (2 mg.ml-l), 10% calf serum or glial growth factor (GGF) at a concentration of 1.8 #g-ml -t. The GGF was a semipure fraction (GGF-CM) prepared by Dr. A. J. D. Goodearl (Ludwig Institute, London) as described elsewhere (47) . Calf serum was added in concentrations ranging from zero to 10%.
Cell Culture in the Presence of Cholera Toxin
Cholera toxin (C'lx) (Sigma Chemical Co., St. Louis, MO) (150 ng.ml -x) was added to Sehwann cell cultures for 1 h at the start of experiments, and 24 hr later for an additional hour. In experiments lasting >4 d, CTx was added for 1 h at 96 and 168 h. As a control for the specificity of the CTx, the ~ subunit was used in some experiments at the same concentration and using a similar regime to that used for CTx.
Cell Culture in the Presence of Forskolin
In some experiments forskolin, a reversible activator of adenyl cyclase was added to cells cultured in media as described above. A 10 mM stock in alcohol was diluted in medium and added at concentrations varying from 0.01 to 200 #M. At the higher concentrations a control containing alcohol alone was added to the experiment. The forskolin was replaced in new medium every 24 h.
Cell Culture in the Presence of cAMP Analogues
In these experiments Schwann cells were placed 6n coverslips coated with 1. Abbreviations used in this paper: BrdU, bromodeoxyuridine; CTx, cholera toxin; GCF, glial growth factor; IBMX, 3-isobutyl-l-methylxanthine; NGFR, nerve growth factor receptor. polylysine, laminin, or extracellular matrix. They were cultured in media as described above, cAMP analogues, NS,2'-O-dibutyryladenosine 3':5'-cyclic monophosphate (db-cAMP) (5 × 10 -4 M) plus 8-bromoadenosine 3':5'-cyclic monophosphate (8 bromo-cAMP) (5 × 10 -4 M) 
Cell Culture in Isobutylmethylxanthine
A 50 mM stock solution of 3-isobutyM-methyl-xanthine (IBMX), an inhibitor of cAMP hydrolysis, (Sigma Chemical Co., St. Louis, MO) in 50% ethanol was diluted 1:5 in PBS. This solution (10 mM in 10% ethanol) was used to give a final dilution of 100 #M in Schwann cell cultures at the start of the experiment. At 24 and 48 h, fresh medium containing 100 I~M IBMX was added to the cultures. Control cultures contained 0.1% ethanol.
Substratum Coating
13-mm-diam round glass coverslips were incubated with polylysine (1 mg.mi -t) at room temperature for 24 h, washed with six changes of sterile distilled water over a period of 4 d, and allowed to dry. Laminin-coated coverslips were prepared by incubating polylysine-coated coverslips with 50 ~tl of laminin solution (Gibco Laboratories) (20 ng-mi -l in DME) for 2 h before plating with Schwann cells. Extracellular matrix coated coverslips were prepared from bovine endothelial cells as described previously (10) and stored in sterile PBS at 4°C until required for use.
Antibodies
Rabbit anti-Po was produced and characterized by Brockes et al. (5) and used at a dilution of 1:200. Rabbit anti-N-CAM was produced and characterized by Gennarini et al. (16) and used at a dilution of 1:500. Rabbit anti-GFAP and rabbit anti-Sl00 (Dako Immunoglobulins A/s; Dakopatts, Copenhagen, Denmark) were used at a dilution of 1:100 and 1:1,000, respectively. Ascites fluid containing mouse mAb to galactocerebroside (IgG3), produced and characterized by Ranscht et al. (44) was used at a dilution of 1:200. Supernatant containing mouse mAb 04 (IgM) (52) was used at a dilution of 1:1. Ascites fluid containing mouse mAb ASE3 (IgG2a) (30) was used at a dilution of 1:500. Ascites fluid to mouse mAb to Po (0.4) produced and characterized by Dr. C. Linington (Max Planck Institut fOr Psychiatric, Martinsreid, FRG) was used at a dilution of 1:500. Mouse monoclonal anti-GFAP (clone G-A-5; Boehringer, Mannheim, FRG) was used at a dilution of 1:4. Mouse mAb 217c supernatant (37) , which has recently been shown to recognize NGFR (15) , was used at a dilution of 1:500. Purified mouse mAb 192-IgG (1.3 mg/ml) (53) which also recognizes NGFR was used at a dilution of 1:1,000. Mouse monoclonal anti-BrdU (Bu20a) (IgG1) supernatant was used at a dilution of 1:20 (17) . Fluorescein or tetramethyl rhodamine-conjugated to goat anti-rabbit Ig (G-antl-RIg-Fl or G-anti-RIg-Rd) (Cappel Laboratories, Ltd., Malvern, PA) absorbed with mouse Ig, were used at a dilution of 1:300. Fluorescein or tetramethyl rhodamine conjugated to goat anti-rabbit Ig (G-anti-MIg-F1 or G-anti-MIgRd) (Cappel Laboratories, Ltd.) absorbed with rabbit Ig, were used at a dilution of 1:150. Biotinylated sheep anti-mouse Ig and streptavidin-Texas Red (Amersham International, Amersham, UK) were both used at a dilution of 1:100.
Immunofluorescence
Antibodies were diluted in MEM-H with 10% calf serum when used on living cells, or in PBS containing 0.1 M lysine, 0.02% sodium azide, and 10% calf serum when used on fixed cells unless otherwise stated. All incubations of cultured cells grown on glass coverslips were carried out at room temperature for 30 rain. Living cells were incubated with 04, galactocerebroside, A5E3, 217c, or 192-IgG antibodies followed by G-anti-MIg-Rd or G-antiMIg-FI, or with N-CAM antibodies followed by G-anti-RIg-Rd or G-antiRIg-F1, then permeabilized in 95% ethanol/5% acetic acid for 10 min at -20"C. The cells were then incubated in Po antiserum followed by G-antiRIg-F1. In some experiments cells were fixed in 95 % ethanol/5 % acetic acid and then incubated in mAbs to Po or GFAP followed by biotinylated sheep anti-mouse Ig then streptavidin-Texas Red. Cells to be labeled with S100 antibodies were fixed in 4 % paraformaldehyde for 20 rain before permeabilization in 95% ethanol/5% acetic acid for 10 rain at -20"C.
DNA Replication
DNA synthesis by Schwann cells was detected by addition of bromodeoxyuridine (BrdU) at a concentration of l0 -5 M for the final 24 h of culture (17) . In double-labeling experiments, with Po antibodies cells were washed and fixed with 95 % ethanol/5 % acetic acid at -20°C for 10 min. They were then treated with 2 N HC1 for about 10 min to denature DNA and 10 min with 0.1 M sodium borate (pH 8.5). Coverslips were incubated sequentially with anti-BrdU in PBS containing 0.1% Triton X-100 for 40 min, with G-anti-MIg-Rd, Po antibodies and G-anti-Rig-F1, all for 30 min. In doublelabeling experiments with 04 antibodies cells were labeled with 04 antibodies followed by G-anti-MIg-Rd, fixed in 2% paraformaldehyde for l0 min, 95 % ethanol/5 % acetic acid, 2 N HCI and sodium borate as above, followed by anti-BrdU and G-anti-MIg-Rd. There was no difficulty in distinguishing 04 surface labeling from the nuclear BrdU labeling despite the fact that both antibodies were monoclonal since the fixations used after use of the first two antibody layers reduced possible cross-reactivity. In some experiments, the number of cells per field (using x63 objective) was counted in cultures that had been subjected to different experimental treatments resulting in various BrdU percentages. It was found that the number of cells per field varied proportionally with the number of BrdU positive cells. This indicates that the BrdU percentage in these experiments is a measure of proliferation. All coverslips were mounted on microscope slides in Citifluor anti-fade mounting medium (Chemistry Department, City University, London, UK). Immunofluorescence was viewed in a Zeiss microscope using ×40 dry or x63 oil-immersion phase contrast lenses, epi-illumination and rhodamine or fluorescein optics.
Immunoblotting
This was carried out using Schwann cells cultured in 75-mm tissue culture flasks coated with polylysine and laminin. Initially, Schwann cells were seeded at 5 x 105-106 Schwann cells per dish and treated with doses of cAMP analogues, forskolin or CTx for 3 d, as described earlier. Cells were cultured in defined medium. Control cultures were maintained without addition of analogues. Proteins were extracted from the cells using 0.1 ml of 2% SDS in 5 mM Tris-Cl, pH 6.8, containing 2 mM EGTA, 2 mM EDTA, and 2 mM PMSF per two dishes. The sample was boiled for 5 min, spun at 14,000 g for 5 min and 10 pl of supernatant withdrawn for protein determination using a protein estimation kit (Bio-Rad Laboratories, Richmond, CA). 2 % mercaptoethanol was then added to the supernatant and the extracts subjected to SDS-PAGE using a 10-15 % gradient acrylamide slab gel. The separated proteins were then transferred to nitrocellulose and immunoblotted essentially as described previously (19) using the Po antiserum at a concentration of 1:5,000, and 125I-labeled donkey anti-rabbit Ig (ICN Biomedicals Lid., Irvine, CA), 15 x 106 cpm/blot diluted in 20 ml of PBS containing 3 % hemoglobin.
Results
cAMP Elevation Induces Expression of the Myelin Protein Po in Short-Term Cultures in Defined Medium
To avoid the complicating effects of serum, which has been included in almost all previous studies on cAMP and Schwann cell differentiation, we initially studied the effect of cAMP elevation on cultured short-term Schwann cells from 5-d rat sciatic nerve in serum-free, defined medium. Under these conditions cAMP does not promote Schwann cell DNA synthesis and the proliferation rate is extremely low (see below). Drug treatment was started after 5 d in vitro. By this time the cells had ceased to express immunohistochemically detectable levels of myelin proteins and glycolipids, such as Po, galactocerebroside, or 04 (22, 29, 32) . We found that 3 d after elevation of cAMP by use of CTx, forskolin or cAMP analogues, expression of the major myelin protein Po was clearly seen in the majority of Schwann cells when they were examined by immunohistochemical methods using Po antibodies. The Po was also induced, albeit to a lesser extent, by IBMX, an inhibitor of phosphodiesterase, as ex- Table II. pected if expression was dependent on cAMP elevation. These results and results from several control experiments are summarized in Table I , and the typical appearance of cells induced to express Po is illustrated in Fig. 1 . Po induction could be detected using either polyclonal or monoclonal Po antibodies, although the MAbs generated a more speckled and less intense labeling pattern. The percentage of cells induced to express Po varied quite widely from experiment to experiment. The highest percentage seen in individual experiments was 84 and 85 % after exposure to forskolin and CTx, respectively, whereas the average percentage was considerably lower (Table I) . When drugs were withdrawn, Po expression declined to undetectable levels (data not shown).
As previously reported, a characteristic morphological change in many of the Schwann cells from a bipolar shape to ceils of a more flattened morphology which were less phase bright, was induced by CTx, forskolin, and cAMP analogues ( Fig. 1) (51) . The induced cells were notably larger in size and more flattened than cells in the same culture which remained uninduced. This difference in responsiveness of individual cells to elevation of cAMP remains unexplained.
No Po was seen in control experiments with the beta subunit of CTx, ethanol, butyrate, GGF, or calf serum or in experiments with serum-free media alone (Table I) .
Po Protein Induced by Elevation of cAMP Can Be Detected in an Immunoblot
When cells were exposed to agents that elevate cAMP or mimic its effect, a clear band of Po protein was detectable by immunoblotting (Fig. 2) . The extract of freshly excised sciatic nerve from a 5-d rat used as a positive control showed a greater intensity of Po protein than the cultured induced cells, even though less total protein was loaded on the gel track. On prolonged exposure of the immunoblot to x-ray film, a very faint band was also visible in the extract of cells cultured for 8 d in the absence of agents which elevate cAMP or mimic its effects, even though no label was visible in immunofluorescence experiments (not shown). This probably indicates that cells from 5-d rats, many of which have already begun to make myelin, continue to synthesize very low residual levels of Po in the absence of axonal contact (39) .
Elevation of cAMP in Cultured Schwann Cells Mimics the Inversion in Protein Expression Characteristic of Myelination In Vivo
When a Schwann cell is induced to form myelin in vivo the induction of myelin specific proteins, such as Po, is followed by down-regulation of a set of proteins that includes GFAP, N-CAM, ASE3, and NGFR (21, 23, 26, 27) . This inversion of protein expression does not occur in non-myelinforming cells, and is reversed on removal of the myelinforming cells from axonal contact. Therefore, in the absence of drug treatment, essentially all the cells in our cultures expressed GFAP, N-CAM, A5E3, and NGFR as reported previously (23), in addition to being Po negative. We found that elevation of cAMP induced the myelination-specific combination of protein up-and downregulation in many cells, since the expression of GFAP, N-CAM, A5E3, and NGFR was strikingly suppressed in a subset of the Po positive cells (Figs. 3, 4 , and 5). The results obtained using the 217c antibody to detect the NGFR (15) were confirmed using the 192-IgG monoclonal, which also detects the NGFR (53) (data not shown). The proportion of Po-positive cells that assumed this more complete myelin phenotype was larger when Po was induced in the presence of serum or GGF although the total number of Po cells was smaller under those conditions (see below).
Induction of the Myelin Phenotype and Cell Division Are Negatively Correlated
The ability of cAMP to induce myelin-related differentiation under conditions allowing proliferation was compared with the induction seen under conditions where DNA synthesis did not occur. The mitogenic response to cAMP elevation was regulated in three ways: (a) by including or excluding serum; (b) by including or excluding GGF; (c) by varying cell density in the presence of serum. Myelin-related differentiation was monitored by Po antibodies and immunohisto- Serum. The ability of cAMP to promote Schwann cell growth depends on the simultaneous activation of at least one other second messenger pathway by agents such as serum or G G E and the mitogenic response to cAMP elevation is low or absent in defined medium (43; Stewart, H. J. S., R. Mirsky, and K. R. Jessen, unpublished). We therefore tested the ability of cAMP analogues to induce Po expression after 3 d and 4 d of exposure to cAMP analogues in the presence of 0% (defined medium), 0.5 and I0% calf serum (Fig. 6 ). This showed that as the amount of serum was increased, the number of Po-positive cells fell very substantially, suggesting a strong negative correlation between proliferation and myelin-related differentiation. Using double label immunofluorescence we then measured simultaneously the number of ceils synthesizing DNA, and the number of cells undergoing myelin-related differentiation in cultures under different conditions. Cultures exposed to cAMP analogues, CTx, or forskolin for 3 d in defined medium on the one hand, and in the presence of 10% calf serum on the other, were compared (see Table II , first four columns). The data demonstrate that there is a strong inverse relationship between Po expression and DNA synthesis.
Glial Growth Factor. To test alternative means of inducing cell division in cultures treated with cAMP elevating agents, we used GGF in serum-free defined medium (Stewart, H. J. S., R. Mirsky, and K. R. Jessen, unpublished) . This greatly increased DNA synthesis and, as in the case of serum, dramatically lowered the percentage of cells that are induced to make Po (see fifth and sixth columns of Table II) .
Cell Density. The common action of serum and GGF on
Schwann cells is to generate conditions under which cAMP elevation increases DNA synthesis and the most likely interpretation of the above results was that a mitogenic response involving cAMP was incompatible with myelin-related differentiation. Alternatively, it was possible that serum and GGF contained factors that directly blocked induction of the myelin phenotype, and that the mitogenic effects of serum and GGF were unrelated to the inhibition of myelin-related differentiation. To test this we took advantage of the observation that Schwann cells show a strong density-dependent inhibition of division. Cells were exposed to agents that elevate cAMP in the presence of 10% calf serum at low plating densities, allowing a strong proliferative response, and at a series of higher densities when proliferation was increasingly suppressed. Cells were plated at densities ranging from 2,500 to 20,000 cells per coverslip and exposed to cAMP analogues for 5 d in in the presence of 10% calf serum. A labeling index of 82 + 4 % was observed at the lowest plating density, and no Po expression was seen. At the highest plating density the labeling index observed was 26 + 6.7 and 21 + 8.5% of the cells expressed Po. Thus, even in the presence of serum an inverse relationship between proliferation and myelin-related differentiation was revealed. When these data (from a total of 28 individual experiments) were analyzed using KendaU's rank correlation test, a rank correlation coefficient, z value of -0.48 (t9 < 0.001) was found, indicating a strong negative correlation between DNA synthesis and Po expression. Furthermore, of all the conditions tested in the present work, cAMP elevation in high-density cultures with 10% calf serum gave the best induction of the myelin phenotype in individual cells, i.e., highest levels of Po expression as judged by the intensity of immunolabeling, and also downregulation of GFAP, N-CAM, A5E3, and NGFR in the largest proportion of the Po-positive cells. Together, these observations exclude the possibility that serum contains factors that directly block cAMP induction of the myelin phenotype, and suggest that serum might in fact contain factors that act together with cAMP to promote maximal expression of the myelin phenotype, provided DNA synthesis is suppressed.
Individual Cells Expressing Po Do Not Incorporate BrrlU and Are Therefore Not Synthesizing DNA
The results above show that Schwann cell populations responded to elevation of cAMP by a high degree of myelinrelated differentiation and low proliferative activity, or by a low level of differentiation and rapid DNA synthesis depending on other conditions in the culture. This suggests that in individual Schwann cells cAMP elevation will either stimulate DNA synthesis or induce myelin-related differentiation, but not both. To test this, DNA synthesis in the Po-negative and -positive Schwann cell populations was compared. In these experirnents plating density was adjusted to obtain substantial proportions of both BrdU-positive cells and of Popositive cells in the presence of cAMP analogues and 10% calf serum (see previous section). In four experiments the number of Po-positive cells averaged 23 + 3.7 % and the number of cells synthesizing DNA within this population was only 0.9 + 0.32%, whereas the number of cells synthesizing DNA within the Po-negative population was 31 + 3.2%. This shows that cells acquiring the myelin-related phenotype and dividing cells are largely nonoverlapping populations, suggesting that DNA synthesis and myelinrelated differentiation are essentially incompatible in individual Schwann cells.
cAMP Induced 04 Expression Is Not Blocked by Proliferation
In vivo, it is clear that full expression of 04, unlike that of Po, is compatible with proliferation during development (29) . To test whether 04 expression and DNA synthesis were compatible in cultured Schwann cells these parameters were monitored in cells exposed for 3 d to 2 /~M forskolin in defined medium and in medium containing GGF. It was found that in defined medium 54 + 8.0% (n = 8) of the Schwann cells were 04 positive (BrdU positive cells <5 %), while in defined medium with GGF 32 + 12.0% (n = 3) of the cells expressed 04 (BrdU-positive cells >80%). This reduction in 04 expression is not statistically significant. Furthermore, in related experiments we found that a large proportion of individual cells responded to cAMP elevation both by DNA synthesis and 04 expression (Fig. 7) . In these experiments, cells were exposed to cAMP analogues in the presence of 10% calf serum, resulting in 04 expression in 88 + 3. 72 + 8.3% incorporated BrdU, whereas 64 + 6.4% within the 04 positive population were also synthesizing DNA.
The Role of Laminin
Laminin-coated substrates were not obligatory for induction of the phenotype, since cells cultured on polylysine-coated coverslips or tissue culture plastic could be induced to make Po in response to elevation of cAMP. In a representative experiment, 63 % of cells plated on laminin and 42 % of cells plated on polylysine expressed Po after a 3-d exposure to cAMP analogues. Extracellular matrix from bovine corneal endothelial cells was also effective although in this case the cells assumed a process-bearing morphology rather than the flattened sheetlike morphology more typical of cells on laminin (data not shown).
Discussion
We have demonstrated that in short-term Schwann cell cultures elevation of intracellular cAMP induces expression of the major myelin protein Po and, in the same cells, suppresses expression of a set of proteins all of which are normally suppressed during myelination in vivo. We find that there is an inverse relationship between induction of the myelin phenotype and DNA synthesis. In contrast, the lipid antigen 04, which is also induced by cAMP elevation, is readily expressed in cells synthesizing DNA.
The Relationship between cAMP, Proliferation, and Differentiation
An inverse relationship between proliferation and differentiation has not been directly demonstrated previously in Schwann cells. It is significant that it was observed only with respect to myelin-related differentiation. This accords well with in vivo development where 04 appears at El6 in proliferating cells, but the formation of the first myelin wrap, which coincides with the onset of high levels of Po expression, is a postmitotic event. Clearly, the effects of cAMP on cultured Schwann cells are quite similar to the effects of the axon-associated signals which regulate 04 expression and myelination since both induce 04 expression in proliferating cells and myelin-related differentiation in quiescent ones.
The existence of an axon-associated mitogen has been convincingly demonstrated in in vitro experiments (46) . It is not clear to what extent this mitogen drives Schwann cell proliferation in embryonic nerves or whether other Schwann cell mitogens, also defined in vitro, play a part. These other mitogens include GGF, PDGF, TGF/~, and FGF (9, (12) (13) (14) 47) . Agents that elevate cAMP levels synergize with all of these polypeptide factors, possibly via upregulation of growth factor receptors (57) . Furthermore, in serum-free medium none of these growth factors stimulate Schwann cell division except when used with agents that elevate cAMP (Stewart, H. J. S., R. Mirsky, and K. R. Jessen, unpublished). Interestingly, mitogenic axonal membranes have been reported to elevate intracellular cAMP in Schwann cells (45) , see, however, Meador-Woodruff et al. (28) for a contrary result.
Together, the present observations and previous work (20, 22, 32, 50, 51) suggest the possibility that axon-associated signals maintain elevated cAMP levels in Schwann cells, (n = 14) (n = 4) (n = 3) (n = 3) (n --3) (n = 3)
For experimental treatment and cell counting procedure see legend to Table I 
Inhibition of Schwann Cell Proliferation
The mechanisms behind the cessation of proliferation that occurs before the formation of the first myelin wrap (56) could include a lowering of growth factor levels, downregulation of receptors, the presence of active inhibitory molecules, or contact inhibition. Modulation of the levels of growth factor receptors on cultured Schwann cells have been described but it is not clear whether those observations are relevant for growth inhibition in vivo (33, 57) . The only identified protein that actively inhibits Schwann cell DNA synthesis in short-term cultured Schwann cells is type 1 collagen (13), whereas growth inhibition of these cells is also caused by an unidentified factor associated with enteric neurons (11) , and by protein secreted by cultured Schwann cells (35) . In view of the possibility that cAMP levels in Schwann cells in normal nerves are higher than those in cultured cells (present paper and references in introduction), it is interesting that provided cAMP levels are elevated in cultured Schwann cells, v-interferon acts as a growth inhibitor (14) . Furthermore, some neurons are known to express interferonlike activity (25) .
Effects of Basal Lamina Components on Induction of the Myelin Phenotype
Studies in vitro have shown that basal lamina formation is a prerequisite for myelin formation (6) . In our studies exogenous laminin did not seem to be strictly required for induction of the myelin phenotype since it could be induced on a polylysine substrate. Laminin is, however, produced by Schwann ceils themselves and treatment with cAMP analogues upregulates expression of laminin in cultured Schwann cells (2, 7) so it is difficult to be definitive on this point. The strikingly flattened shape of induced cells on laminin does suggest that it might play a role in the expansion and flattening of the Schwann cell that is required when the Schwann cell wraps around the axon and makes myelin in vivo.
Comparison with Previous Experiments on cAMP Induction and Schwann Cell Differentiation
Our results on induction of the myelin phenotype by elevation of intracellular cAMP complement and extend those of others. The original experiments of Sobue and Pleasure (50, 51) showing that galactocerebroside could be induced in short-term Schwann cells treated with high doses of cAMP analogues or high doses of forskolin suggested a role for cAMP in Schwann cell differentiation. Shuman et al. (49) reported that another myelin-related protein, PlT0r, could be induced in short-term Schwann cell cultures using 8 bromocAMP (5 x 10 -~ M to 3 x 10 -3 M) or forskolin (100 #M) in medium with 10% calf serum. They were, however, unable to induce Po under these conditions. In view of the results reported in the present paper it seems likely that this failure can be traced to a high level of cell division, which was not monitored in these experiments. Using immunoblotting and Northern blotting techniques, induction of Po and Po mRNA by 2/zM forskolin and of myelin basic protein mRNA by 20/~M forskolin in the presence of 10% FCS has been reported in passaged Schwann cells that have been previously exposed to forskolin and GGF for 3--4 wk (24) . The induction of the POU-domain SCIP gene mRNA before induction of Po mRNA in the same culture system has been recently suggested as an important step in the series of events by which elevation of cAMP triggers myelin formation in Schwann cells (34) . Cell division was not measured in these experiments. It should be noted that exposure of long term secondary Schwann cellsto mitogenic doses of forskolin and GGF leads ultimately to constitutive expression of Po even when mitogens are withdrawn (24, 40, 41) . Constitutive expression of Po has also been reported in long-term Schwann cells treated with CTx (54) . Thus regulation of Po may be less stringent in long-term than in short-term cultured Schwann cells. In developing nerve, there are no biochemical data on cAMP levels. These would, in any case, be difficult to interpret since cAMP levels in axons, Schwann cells and fibroblastic cells of the endo-, peri-, and epineurium would all contribute to the measureit overall level. It has been reported that cAMP levels in the adult rabbit sciatic nerve rise significantly in the distal stump of the nerve within 1-6 h after crush injury (1) a situation in which cell proliferation is initiated in previously quiescent Schwann cells, probably in response to macrophage invasion (3, 38) .
Conclusions
Elevation of cAMP levels mimics events in Schwann cell development that take place in vivo from El6 onwards. These include induction of 04 antigen in the presence of DNA synthesis and induction of the myelin phenotype in quiescent cells. This suggests that in Schwann cells cAMP elevation may be a primary developmental signal, with a more general action than hitherto envisaged. Neither the present data, nor previous work on galactocerebroside and 04 induction, are consistent with the idea that cAMP elevation specifically triggers myelination. Rather, we suggest that secondary signals removing cells from the cell cycle effectively act as the myelination trigger, since this would permit the ongoing cAMP elevation to induce myelin-specific differentiation.
